Oasmia Pharmaceutical AB announces the appointment of Dr. Heidi B. Ramstad as Chief Medical Officer reporting to Dr. Francois Martelet, Chief Executive Officer. Dr. Ramstad will join Oasmia in her new role no later than March 1st, 2021. Dr. Ramstad replaces Dr. Reinhard Koenig, Oasmia's acting Chief Medical Officer. Dr. Koenig, who is based on the East Coast of the US, will continue to advise Oasmia at a senior level. Dr. Ramstad has more than 20 years' experience as a medical doctor and biopharmaceutical executive in the healthcare sector. Recent positions include working for Nisonic as Chief Medical Officer and as Managing Director at NorMed Consulting.